TIAA FSB’s Novartis NVS Stock Holding History

TIAA FSB’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$699K	Sell	6,930 -24	-0.3%	-$2.4K	﹤0.01%	372
2023 Q1	$640K	Sell	6,954 -278	-4%	-$24.3K	﹤0.01%	378
2022 Q4	$656K	Sell	7,232 -536	-7%	-$45.1K	﹤0.01%	376
2022 Q3	$590K	Sell	7,768 -1,109	-12%	-$91.9K	﹤0.01%	381
2022 Q2	$750K	Sell	8,877 -1,633	-16%	-$143K	﹤0.01%	364
2022 Q1	$922K	Sell	10,510 -703	-6%	-$60.9K	﹤0.01%	317
2021 Q4	$981K	Sell	11,213 -508	-4%	-$42.2K	﹤0.01%	309
2021 Q3	$958K	Sell	11,721 -92	-0.8%	-$8.28K	﹤0.01%	306
2021 Q2	$1.08M	Sell	11,813 -356	-3%	-$31.7K	﹤0.01%	309
2021 Q1	$1.04M	Sell	12,169 -335	-3%	-$30.1K	﹤0.01%	299
2020 Q4	$1.18M	Buy	+12,504	New	+$1.09M	﹤0.01%	281
2019 Q2	–	Sell	-15,048	Closed	-$1.3M	–	311
2019 Q1	$1.3M	Sell	15,048 -1,952	-11%	-$157K	0.01%	242
2018 Q4	$1.31M	Sell	17,000 -1,401	-8%	-$109K	0.01%	240
2018 Q3	$1.42M	Sell	18,401 -4,188	-19%	-$310K	0.01%	252
2018 Q2	$1.53M	Sell	22,589 -4,541	-17%	-$313K	0.01%	241
2018 Q1	$1.97M	Sell	27,130 -6,129	-18%	-$467K	0.01%	228
2017 Q4	$2.5M	Buy	33,259 +3,214	+11%	+$243K	0.01%	226
2017 Q3	$2.31M	Buy	30,045 +2,937	+11%	+$222K	0.01%	231
2017 Q2	$2.03M	Buy	+27,108	New	+$1.92M	0.01%	233

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TIAA FSB's NVS Position: Q2 2023 in Review

TIAA FSB reduced its Novartis (NVS) stake by 0.35% in Q2 2023, selling an estimated $2.4K and leaving 6,930 shares worth $699K. The position accounts for ﹤0.01% of the portfolio, ranked #372.

TIAA FSB first reported a position in NVS in Q2 2017 and has held it in 19 quarters since. The position peaked at $2.5M in Q4 2017. 1,202 funds tracked by Wall St. Rank hold NVS as of Q2 2023.

TIAA FSB held 6,930 shares of Novartis worth $699K as of Q2 2023.
TIAA FSB sold 24 Novartis shares in Q2 2023, an estimated $2.4K.
Novartis made up ﹤0.01% of TIAA FSB's portfolio in Q2 2023, its #372 holding.
TIAA FSB first reported a position in Novartis in Q2 2017 and has held it in 19 quarters since.
TIAA FSB's Novartis position peaked at $2.5M in Q4 2017.
1,202 funds tracked by Wall St. Rank held Novartis as of Q2 2023.

Based on TIAA FSB's 13F filing for Q2 2023, filed 31 Jul 2023.